Your browser doesn't support javascript.
loading
Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada, Chelsea; Steain, Megan; Campbell, Tessa Mollie; McSharry, Brian; Slobedman, Barry; Abendroth, Allison.
Afiliação
  • Gerada C; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia.
  • Steain M; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia.
  • Campbell TM; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia.
  • McSharry B; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia.
  • Slobedman B; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia.
  • Abendroth A; Discipline of Infectious Diseases and Immunology, The University of Sydney, Camperdown, New South Wales, Australia allison.abendroth@sydney.edu.au.
J Virol ; 93(22)2019 11 15.
Article em En | MEDLINE | ID: mdl-31462576
ABSTRACT
Immune regulation of alphaherpesvirus latency and reactivation is critical for the control of virus pathogenesis. This is evident for herpes simplex virus 1 (HSV-1), where cytotoxic T lymphocytes (CTLs) prevent viral reactivation independent of apoptosis induction. This inhibition of HSV-1 reactivation has been attributed to granzyme B cleavage of HSV infected cell protein 4 (ICP4); however, it is unknown whether granzyme B cleavage of ICP4 can directly protect cells from CTL cytotoxicity. Varicella zoster virus (VZV) is closely related to HSV-1; however, it is unknown whether VZV proteins contain granzyme B cleavage sites. Natural killer (NK) cells play a central role in VZV and HSV-1 pathogenesis and, like CTLs, utilize granzyme B to kill virally infected target cells. However, whether alphaherpesvirus granzyme B cleavage sites could modulate NK cell-mediated cytotoxicity has yet to be established. This study aimed to identify novel HSV-1 and VZV gene products with granzyme B cleavage sites and assess whether they could protect cells from NK cell-mediated cytotoxicity. We have demonstrated that HSV ICP27, VZV open reading frame 62 (ORF62), and VZV ORF4 are cleaved by granzyme B. However, in an NK cell cytotoxicity assay, only VZV ORF4 conferred protection from NK cell-mediated cytotoxicity. The granzyme B cleavage site in ORF4 was identified via site-directed mutagenesis and, surprisingly, the mutation of this cleavage site did not alter the ability of ORF4 to modulate NK cell cytotoxicity, suggesting that ORF4 has a novel immunoevasive function that is independent from the granzyme B cleavage site.IMPORTANCE HSV-1 causes oral and genital herpes and establishes life-long latency in sensory ganglia. HSV-1 reactivates multiple times in a person's life and can cause life-threatening disease in immunocompromised patients. VZV is closely related to HSV-1, causes chickenpox during primary infection, and establishes life-long latency in ganglia, from where it can reactivate to cause herpes zoster (shingles). Unlike HSV-1, VZV only infects humans, and there are limited model systems; thus, little is known concerning how VZV maintains latency and why VZV reactivates. Through studying the link between immune cell cytotoxic functions, granzyme B, and viral gene products, an increased understanding of viral pathogenesis will be achieved.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Herpesvirus Humano 1 / Herpesvirus Humano 3 / Granzimas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Herpesvirus Humano 1 / Herpesvirus Humano 3 / Granzimas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2019 Tipo de documento: Article